New chiral N-(N,N-dialkylamino)sulfamoyl-1,2-diamine ligands for highly enantioselective transfer hydrogenation of ketones
摘要:
Chiral Ru(II) and Rh(III) complexes of N-(N,N-dialkylamino)sulfamoyl-1,2-diamine catalyze the transfer hydrogenation of various classes of aromatic ketones with high activity and excellent enantioselectivity. (C) 2002 Elsevier Science Ltd. All rights reserved.
Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
申请人:——
公开号:US20020160978A1
公开(公告)日:2002-10-31
This invention provides a method for the treatment of a subject in need of treatment for osteoarthritis comprising administering to said subject an amount of an inhibitor of spermidine biosynthesis sufficient to effect a substantial inhibition of spermidine biosynthesis. This invention also provides the use of an inhibitor of spermidine biosynthesis in the treatment of a subject in need of treatment of osteoarthritis in an amount sufficient to effect a substantial inhibition of spermidine biosynthesis. This invention further provides a method of preparing a therapeutic composition for the treatment of a subject in need of a treatment for osteoarthritis and the invention further provides a method of identifying an inhibitor of spermidine biosynthesis, whereby the inhibitor is a spermidine synthase inhibitor.
INHIBITORS OF SPERMIDINE SYNTHASE FOR THE TREATMENT OF OSTEOARTHRITIS AND CARTILAGE REHABILITATION
申请人:Quark Biotech, Inc.
公开号:EP1357881A2
公开(公告)日:2003-11-05
EP1357881A4
申请人:——
公开号:EP1357881A4
公开(公告)日:2009-02-18
US6696454B2
申请人:——
公开号:US6696454B2
公开(公告)日:2004-02-24
[EN] INHIBITORS OF SPERMIDINE SYNTHASE FOR THE TREATMENT OF OSTEOARTHRITIS AND CARTILAGE REHABILITATION<br/>[FR] INHIBITEURS DE LA SPERMIDINE SYNTASE POUR LE TRAITEMENT DE L'ARTHROSE ET POUR LA REHABILITATION DU CARTILAGE
申请人:QUARK BIOTECH INC
公开号:WO2002058623A2
公开(公告)日:2002-08-01
This invention provides a method for the treatment of a subject in need of treatment for ostheoarthritis comprising administering to said subject an amount of an inhibitor of spermidien biosynthesis sufficient to effect a substantial inhibition of spermidien biosynthesis. This invention also provides the use of an inhibitor of spermidine biosynthesis in the treatment of a subject in need of treatment of osteoarthritis in an amount sufficient to effect a substantial inhibition of spermidine biosynthesis. This invention further provides a method of preparing a therapeutic composition for the treatment of a subject in need of a treatment for osteoarthritis and the invention further provides a method of identifying an inhibitor of spermidine biosynthesis, whereby the inhibitor is a spermidine synthase inhibitor.